Literature DB >> 15380233

Piperidine-containing beta-arylpropionic acids as potent antagonists of alphavbeta3/alphavbeta5 integrins.

Bart L De Corte1, William A Kinney, Li Liu, Shyamali Ghosh, Livia Brunner, William J Hoekstra, Rosemary J Santulli, Robert W Tuman, Judith Baker, Candace Burns, Jef C Proost, Brett A Tounge, Bruce P Damiano, Bruce E Maryanoff, Dana L Johnson, Robert A Galemmo.   

Abstract

The synthesis and SAR of a new class of piperidine-based alphavbeta3/alphavbeta5 integrin antagonists is described. Replacement of an amide bond in a prototype isonipecotamide by a C-C isostere, and adjustment of the spacer length between the carboxylic acid and basic moieties, led to low nanomolar antagonists of alphavbeta3 and/or alphavbeta5 integrins with excellent selectivity versus alpha(IIb)beta3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380233     DOI: 10.1016/j.bmcl.2004.06.061

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2015-08-03       Impact factor: 4.774

2.  Glycoprotein IIb/IIIa receptor imaging with 18F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study.

Authors:  Chanwoo Kim; Jae Seung Lee; Youngjin Han; Sun Young Chae; Soyoung Jin; Changhwan Sung; Hye Joo Son; Seung Jun Oh; Sang Ju Lee; Jungsu S Oh; Yong-Pil Cho; Tae-Won Kwon; Deok Hee Lee; Seongsoo Jang; Bohyun Kim; Norman Koglin; Mathias Berndt; Andrew W Stephens; Dae Hyuk Moon
Journal:  J Nucl Med       Date:  2018-06-29       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.